PPAG Courses RSS Feed

Core Competency Series: Pediatric Parenteral Nutrition

noemail@ppag.org — Fri, 19 Mar 2010 13:00:00 GMT

Objectives:

At the end of this session, the participant will be able to:

1. List and discuss the common complications of PN.

2. Explain why neonates and infants require a specialized amino acid solution when receiving PN.

3. Identify the indications and monitoring parameters for an infant receiving PN.

Instructor: Kathleen Gura, PharmD

Release Date: 19-Mar-10 8:00 AM
Expiration Date: 19-Mar-13 8:00 AM

This program is a one hour Power Point presentation with synched audio. To begin this program, please click the "start" icon below. You can follow along by downloading the handout below. To download the course handout (PDF), click here. After completion of the program, you may take the post-test to receive credit.

Extreme Dosing in Overweight/Obese Children - Focus on DVT Prophylaxis

noemail@ppag.org — Fri, 19 Mar 2010 13:00:00 GMT

Objectives:

At the end of this session, participants will be able to:

1. Define the categories for overweight/obesity according to BMI percentiles in children.

2. Describe the pharmacokinetic alterations of enoxaparin in overweight/obese children.

3. Provide recommendations for enoxaparin dosing in overweight/obese children.

Instructor: Peter Johnson

Release Date: 19-Mar-10 8:00 AM
Expiration Date: 19-Mar-13 8:00 AM

Extreme Dosing: Case Studies in Pediatric Transplantation

noemail@ppag.org — Fri, 19 Mar 2010 13:00:00 GMT

Objectives:

At the end of this session, participants will be able to:

1. To list specific situations where extreme dosing is utilized in pediatric transplant recipients.

2. To list drugs, drug combinations, and doses utilized in extreme dosing situations in pediatric transplant recipients.

3. to contrast the benefits and risks associated with extreme dosing in pediatric transplant recipients.

4. To list monitoring procedures to avoid toxicity and to assess efficacy and outcomes of extreme dosing in pediatric transplant recipients.

Instructor: William McGhee

Release Date: 19-Mar-10 8:00 AM
Expiration Date: 19-Mar-13 8:00 AM

Extreme Dosing in CF: Aminoglycosides

noemail@ppag.org — Fri, 19 Mar 2010 13:00:00 GMT

Objectives:

At the end of this session, participants will be able to:

1. Identify pharmacokinetic differences between Cystic Fibrosis patients and non-Cystic Fibrosis patients.

2. Describe the rationale for high dose aminoglycosides in the Cystic Fibrosis population.

3. Design a high dose aminoglycoside regimen for a patient with Cystic Fibrosis.

Instructor: Heidi Smith Hoopingarner

Release Date: 19-Mar-10 8:00 AM
Expiration Date: 19-Mar-13 8:00 AM

Hot Topics in Pediatric ID, Critical Care, and Nutrition

noemail@ppag.org — Sun, 27 Sep 2009 13:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. Identify recent developments in the field of pediatric critical care and their impact to clinical practice.

2. Summarize recent developments in the field of pediatric infectious diseases and their impact to clinical practice.

3. Describe the changes for Synagis administration for at-risk infants based on new guidelines.

4. Understand the new vitamin D guidelines including RDA for infants and children.

5. Determine when repeat courses of antenatal steroids could be used in at-risk patients.

Instructor: Jeff Cies, PharmD and Betsy Walter, PharmD

Release Date: 27-Sep-09 8:00 AM
Expiration Date: 27-Sep-12 8:00 AM

This program is a two hour Audio presentation synced with PowerPoint slides. The program contains three sections.

To begin this program, please click the "start" icon below. You can follow along by downloading the handout below. To download the PDF documents for each section, please click the "go" button below. After completion of the program, you may take the post-test to receive credit.

Medication Use During ECMO and Continuous Renal Replacement Therapy

noemail@ppag.org — Sat, 26 Sep 2009 13:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. Describe the basic mechanics of Extracorpeal Membrane Oxygenation (ECMO).

2. Describe the basic mechanics of Continuous Renal Replacement Therapy (CRRT).

3. Discuss modification of drug therapy based on the effects of extracorporeal circuits.

Instructor: Brenda Dodson

Release Date: 26-Sep-09 8:00 AM
Expiration Date: 26-Sep-12 8:00 AM

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the "start" icon below. You can follow along by downloading the handout below. To download the PDF document, please click the "go" button below. After completion of the program, you may take the post-test to receive credit.

Community-Acquired MRSA in Pediatric Patients

noemail@ppag.org — Sat, 26 Sep 2009 13:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. Describe the difference between hospital-acquired and community-acquired MRSA infections.

2. When given a susceptibility report, be able to select an appropriate antimicrobial agent for a patient with an infection due to community-acquired MRSA.

3. Describe the treatment implications for a patient who has developed Panton-Valentine leukocidin (PVL) syndrome.

Instructor: Kristin Klein, PharmD

Release Date: 26-Sep-09 8:00 AM
Expiration Date: 26-Sep-12 8:00 AM

Adolescents, Sexuality, and The Pediatric Pharmacist

noemail@ppag.org — Fri, 25 Sep 2009 13:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. Discuss adolescent sexuality and the developmental and socio-environmental context which it develops.

2. Describe recent trends in adolescent sexual reproductive health.

3. Discuss the implications of current initiatives to promote adolescent sexual and reproductive health on pediatric pharmacy practice, including emergency contraception provision and expedited partner treatment.

Instructor: Veenod Chulani

Release Date: 25-Sep-09 8:00 AM
Expiration Date: 25-Sep-12 8:00 AM

Management of Pediatric Chemical Casualties: Are We Prepared

noemail@ppag.org — Fri, 25 Sep 2009 13:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. Identify two risk factors that put pediatric patients at higher risk of toxicity from a chemical release compared to adults.

2. List two special considerations for the decontamination of children that must be addressed in emergency plans.

3. Describe two reasons why it is critical to develop an emergency cache at your hospital.

Instructor: Elora Hilmas

Release Date: 25-Sep-09 8:00 AM
Expiration Date: 25-Sep-12 8:00 AM

Core Competency Series: Management of Diabetes Type 1

noemail@ppag.org — Thu, 24 Sep 2009 18:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. Compare the advantages and disadvantages of various insulin regimens.

2. Determine patient-specific factors to consider when selecting an insulin regimen.

3. Given a patient case, design a home insulin regimen for a child with Type 1 diabetes.

Instructor: Michelle Condren

Release Date: 24-Sep-09 1:00 PM
Expiration Date: 24-Sep-12 1:00 PM

Core Competency Series: DKA & HHS

noemail@ppag.org — Thu, 24 Sep 2009 18:00:00 GMT

Objectives:

At the conclusion of this program, particpants will be able to:

1. Discover how the pathophysiology of DKA contributes to its clinical presentation.

2. Develop a treatment plan for a patient in DKA.

3. Distinguish HHS from DKA in the areas of pathophysiology, presentation, and management.

Instructor: Mark Haase

Release Date: 24-Sep-09 1:00 PM
Expiration Date: 23-Sep-12 1:00 PM

Core Competency Series: Management of Diabetes, Type II

noemail@ppag.org — Thu, 24 Sep 2009 18:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. State the epidemiology and pathophysiology of type 2 diabetes mellitus (T2DM) in the pediatric population.

2. Identify the opinions, barriers, and current practices related to T2DM screening in children.

3. List the challenges of treatment of T2DM in children, assess current therapeutic options, and summarize the literature supporting oral therapies for the treatment of pediatric T2DM.

Instructor: Allison Blackmer

Release Date: 24-Sep-09 1:00 PM
Expiration Date: 23-Sep-12 1:00 PM

Core Competency Series: Pumps, Pens, and other Devices

noemail@ppag.org — Thu, 24 Sep 2009 18:00:00 GMT

Objectives:

At the conclusion of this program, participants will be able to:

1. Describe the functional parameters of insulin pens, subcutaneous injection ports, continuous glucose monitors and subcutaneous insulin infusion pumps.

2. Determine the roles for insulin pens, subcutaneous injection ports, continuous glucose monitors and subcutaneous insulin infusion pumps in the management of diabetes mellitus (DM) in children.

3. Given a patient case, design or adjust an insulin pump regimen for a child with DM.

Instructor: Thomas Parker

Release Date: 24-Sep-09 1:00 PM
Expiration Date: 23-Sep-12 1:00 PM

Core Competency Series: Bronchopulmonary Dysplasia: Diagnosis, Prevention, and Treatment

noemail@ppag.org — Wed, 25 Mar 2009 13:00:00 GMT

Objectives:

Upon completion of this program, participants will be able to:

Describe the challenges of defining bronchopulmonary dysplasia (BPD)
Review the multi-factorial influences on the development of BPD and identify potential drug targets
Evaluate the evidence supporting the use of drugs to prevent the development of BPD
Discuss the efficacy of drugs use for the treatment of established BPD

Instructor: Sherry Luedtke, PharmD

Release Date: 25-Mar-09 8:00 AM
Expiration Date: 25-Mar-12 11:45 PM

This program is a one hour audio recording. To begin this program, please click the "start" icon below. You can follow along by downloading the handout below. To download the PDF document, please click the "go" button below. After completion of the program, you may take the post-test to receive credit.

Core Competency Series: Physiologic and Pharmacokinetic Differences in Children, Fluids and Electrolytes and Dehydration in Children

noemail@ppag.org — Mon, 28 Apr 2008 13:00:00 GMT

Objectives:

At the end of this session, participants will be able to:

Understand the developmental reason children are heart rate dependent
Comprehend why respiratory diseases are more common in infants and toddlers
Understand the immunologic reason for more aggressive antibiotic treatment of febrile children
Describe the differences in pharmacokinetic parameters between children and adults
Translate basic principles of pediatric pharmacokinetics into practice and describe new research in the field of developmental pharmacology and pharmacogenomics
Using neonatal sepsis is an example, explain how gentamicin dosing an monitoring should be adjusted for neonatal patient
Describe basic fluid and electrolyte requirements for children in all age groups
Explain causes and effects of dehydration in children
Review methods for managing fluid and electrolyte abnormalities and explain the accompanying monitoring parameters

Instructor: Elizabeth Farrington, Content Coordinator

Release Date: 28-Apr-08 8:00 AM
Expiration Date: 9-May-14 11:00 PM

To complete this series, please click on the modules below, view the presentations. After you complete the modules return to this screen to complete the online post-test.

Handouts: